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Abstract 
 Impulsivity has been implicated in many different neuropsychiatric disorders, such as 
VXEVWDQFHXVHGLVRUGHUV$O]KHLPHU¶V'LVHDVHDQGVFKL]RSKUHQLD,QSUHYLRXVUHVHDUFKWKH
effects of nicotine on attention and delay discounting have been well established.  However, 
delay discounting represents just one aspect of impulsivity, and the other aspects have not been 
as well studied.  The probability-discounting task is frequently used to measure the risky 
behavior aspect of impulsivity in animal models.  We have found that exposure to nicotine, 
abstinence, and re-exposure to nicotine results in riskier behavior in rats.  To test if this behavior 
LVPHGLDWHGE\WKHĮȕQLFRWLQLFDFHW\OFKROLQHUHFHSWRUVZHWKHQDGPLQLVWHUHGDQĮȕ
nicotinic acetylcholine receptor antagonist, dihydro-ȕ-ethyroidine, and found that the observed 
behavior on the probability-GLVFRXQWLQJWDVNLVQRWPHGLDWHGE\WKHĮȕQLFRWLQLFDFHW\OFKROLQH
receptors.     
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Introduction 
 Impulsivity has been implicated in drug addiction many times in humans and in animals 
(Kelsey and Niarula 2013, Weafer and de Wit 2013).  Nicotine addiction frequently is comorbid 
with other addictions and behaviors that could be described as impulsive disorders or that have 
aspects of impulsive disorders (Potter and Newhouse 2008).  However, the research on the 
effects of nicotine on impulsivity and on the actions of nicotinic acetylcholine receptors 
(nAChRs) has been contradictory.  Moreover, little research has examined the effects of periods 
of nicotine exposure and abstinence on impulsivity.  This research has clinical implications for 
understanding how impulsivity may be altered when individuals begin to try to stop smoking.  
The goals of these experiments were (1) to address this gap in the literature and (2) to asses the 
UROHRIWKHĮȕQLFRWLQLFDFHW\OFKROLQHUHFHSWRUVLQLPSXOVLYHEHKDYLRU 
Impulsivity 
 Impulsive behavior is clinically defined as actions that are poorly conceived, prematurely 
expressed, unduly risky, or inappropriate to the situation and that often result in undesirable 
outcomes (Ohmura et al. 2012).  From that broad definition, impulsivity can be subdivided into 
four categories: reflection impulsivity, impulsive action, impulsive choice, and risky behavior.  
Each aspect of impulsivity can be measured in a number of ways, contributing to the 
discrepancies seen in the literature.  Impulsive choice can also be further subdivided into delay-
discounting and probability-discounting, which are measured with their respective tasks.  In a 
delay-discounting task, impulsivity is defined as a greater tendency to value or choose smaller, 
more immediate rewards over larger, more delayed rewards, even when it is advantageous to 
choose the larger, delayed reward.  In other terms, impulsivity is a lack of delayed gratification.  
In contrast, the probability-discounting task, while still being a measure of impulsive choice, is 
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more of a measure of risky behavior (Mendez et al. 2013).  Risky behavior is defined as placing 
oneself in an unsafe situation that can lead to dangerous consequences (Ohmura et al. 2012).  
With this definition in mind, in a probability-discounting task, choosing the larger, riskier reward 
is interpreted as impulsive behavior.  
 Impulsivity appears to be mediated by the medial prefrontal cortex (mPFC), and the 
various aspects of impulsivity are dissociable.  The prelimbic mPFC has been implicated in 
mediating risky decision making (St Onge and Floresco 2009).  The orbitofrontal cortex is 
involved in delay-discounting behavior and the dorsal anterior cingulated cortex has been 
implicated in mediating effort-based decision making (Congdon et al 2013).   
Actions of nicotine in the brain: roles of nicotinic receptor subtypes 
 Nicotine binds to nicotinic acetylcholine receptors in the brain.  These receptors are 
ionotropic and are made of pentameric combinations of ĮĮ-ĮDQGȕȕ-ȕVXEXQLWVZKLFK
DUHFRXSOHGWRVRGLXPFKDQQHOV,QWKHKXPDQFHQWUDOQHUYRXVV\VWHPWKHĮȕDQGĮVXEW\SHV
are the most widely distributed (Nashmi and Lester 2006).  The cholinergic system in the brain is 
primarily modulatory, anGVRĮȕQ$&K5VDUHORFDWHGSUHV\QDSWLFDOO\5HFHSWRUVWKDWDUH
located presynaptically generally moderate how another neurotransmitter is released.  Dȕ
nAChRs are expressed in the parietal cortex, cingulate cortex, subiculum, substantia nigra, 
superior colliculus, medial geniculate nucleus, lateral-dorsal tegmental nucleus, and in lower 
OHYHOVLQWKHQXFOHXVDFFXPEHQV1DVKPLDQG/HVWHU,QDGGLWLRQĮDQGȕP51$VDUH
transcribed in every dopaminergic and GABAergic neuron in the ventral tegmental area.  E2 
containing receptors are dense in the limbic system, suggesting that these nicotinic acetylcholine 
receptors are responsible for the reward-like behavior and relieving negative affect responsible 
for maintaining addiction (Anderson and BrunzeOO$FWLYDWLRQRIȕFRQWDLQLQJQ$&K5V
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causes the reinforcement of reward-OLNHEHKDYLRUDQGLQDFWLYDWLRQRIWKHȕFRQWDLQLQJUHFHSWRUV
decreases anxiety and fear-OLNHEHKDYLRU7KHVHȕUHFHSWRUVDOVRKDYHDKLJKELQGLQJDIILQLW\
for nicotine and endogenous acetylcholine (Anderson and Brunzell 2012).  In fact, nicotine has 
DQHIILFDF\HTXLYDOHQWWRWKDWRIDFHW\OFKROLQHRQWKHĮȕQ$&K5V$QGHUVRQDQG%UXQ]HOO
2012).       
 Nicotinic acetylcholine receptors are unique in that they can experience multiple states of 
activation.  An agonist can activate a nAChR in the traditional sense, but prolonged exposure to 
an agonist can cause a conformational change in the receptor that decreases its responsivity to be 
activated.  This is known as a desensitizing effect and is similar to nAChR blockade by an 
antagonist (Levin 2013).  Desensitization can occur after prolonged and repeated exposure to an 
agonist or after prolonged exposure to subactivating concentrations (Wageman et al. 2013).  The 
desensitization by subactivating concentrations can help to explain the actions of nicotine at low 
doses.  Acetylcholine does activate and then desensitize the nAChRs as well, but it is degraded 
so quickly that the receptors are able to recover fairly rapidly.  Nicotine is metabolized much 
slower than acetylcholine, so the receptor desensitization is prolonged.  Nicotinic acetylcholine 
UHFHSWRUVFDQDOVRH[LVWLQDVWDWHRI³VPROGHULQJDFWLYDWLRQ´ZKHUHVRPHQLFRWLQLFDFHW\OFKROLQH
receptors are desensitized and some are activated (Campling et al. 2013).  This effect occurs in 
vivo because nicotine and other agonists can remain in the tissue for hours after drug 
administration.  The smoldering activation depends very much on agonist concentrations.  In the 
day of the average smoker, the levels of nicotine that are present vary greatly.  When waking up 
in the morning after a night of not smoking, the free brain level of nicotine can be as low as 
25nM, but can be as high as 465nM in the afternoon after a day of smoking (Rose et al. 2010).  
The variable concentrations of nicotine could be responsible for the various behavioral effects.  
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Anderson and Brunzell (2012) showed that low doses of nicotine reduce anxiety, medium doses 
of nicotine support reward-like behavior, and high doses of nicotine increase anxiety.  The dual 
UROHRIWKHȕFRQWDLQLQJQLFRWLQLFDFHW\OFKROLQHUHFHSWRUVFDQEHDWWULEXWHGWRVPROGHULQJ
DFWLYDWLRQ7KHLQDFWLYDWLRQRIWKHȕFRQWDLQLQJUHFHSWRUVLVDUHVXOWRIGHVHQVLWL]DWLRQDQG
causes the decreased anxiety.  The activation causes the reward-like behavior, and both of these 
effects are present simultaneously in smokers (Anderson and Brunzell 2012).  At physiological, 
VXVWDLQHGFRQFHQWUDWLRQVRIQLFRWLQHVHHQLQDFWLYHVPRNHUVWKHPDMRULW\RIĮȕQ$&K5VDUH
VDWXUDWHGEXWWKHĮQ$ChRs should not be affected (Campling et al. 2013).  Because nAChRs 
are especially prone to being desensitized, it can be difficult to predict if an agonist is exerting its 
effect because of activation or desensitization.   It may be such that, if the main effects of 
nicotine or other nAChR agonists are because of receptor desensitization and not activation, then 
the effects may rely on the binding affinity of the ligands, not efficacy.  
 Nicotine administration causes changes in nicotinic acetylcholine receptor expression.  In 
contrast to how most neurotransmitter systems behave, chronic nicotine treatment causes a dose-
GHSHQGHQWXSUHJXODWLRQRIĮȕUHFHSWRUGHQVLW\LQWKHEUDLQVRIPLFHDQGUDWV.DVVLRXHWDO
2001).  The receptor upregulation is not permanent, and smokers who had abstained for 2 months 
KDGQRUPDOĮȕQ$&K5GHQVLW\7KHĮȕXSUHJXODWLRQLVVHHQPRVWO\LQWKHWKDODPXVDQG
cerebellum (but see also Colombo et al. 2013).       
 The thalamus has the highest density of nicotinic acetylcholine receptors in the brain, and 
has been implicated in mediating many of the cognitive benefits of nicotine (Levin 2013).  The 
nucleus accumbens has been implicated in impulsivity.  Specifically, bilateral excitotoxic lesion 
of the nucleus accumbens core increased impulsive choice on a delay-discounting task (Dalley et 
al. 2008).  The same effect was not seen by lesioning the nucleus accumbens shell.  Interestingly, 
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the same study also showed that by lesioning both the nucleus accumbens core and nucleus 
accumbens shell, preference for a larger, delayed reward increased.  This supports the finding 
WKDWFKRLFHRIWKHODUJHUFRVWO\UHZDUGLQERWKWKH''7DQG3'7ZDVLQYHUVHO\UHODWHGWRĮȕ
receptor binding in the nucleus accumbens shell (Mendez et al. 2013).  'HFUHDVHGĮȕUHFHSWRU
binding in the nucleus accumbens shell should increase preference for the large reward in a 
delay-discounting task.  With this evidence, it is possible that stimulation of the D4E2 nAChRs in 
the nucleus accumbens through nicotine administration mediates impulsivity.  The anterior 
cingulate cortex and the orbitofrontal cortex have also been implicated in decision-making.  
Lesioning the anterior cingulate cortex decreased preference for a large reward/high effort over a 
small reward/low effort option, suggesting that this area is sensitive to effort, not discounting (St 
Onge and Floresco 2009).  Lesions in the orbitofrontal cortex altered behavior in the DDT, 
suggesting that the orbitofrontal cortex plays a role in delay reinforcement (Dalley et al. 2008).  
Many studies have shown that several different brain regions are responsible for the varied facets 
of decision-making, but the thalamus, nucleus accumbens core, and orbitofrontal cortex are the 
areas most involved in delay- and probability-discounting.        
Nicotine and Cognition 
 The cognitive benefits of nicotine have been well documented (Kumari et al., 2003; 
Levin et al., 2000; Lawrence et al., 2002).  However, nicotinic acetylcholine receptor blockade or 
desensitization has also been reported to enhance cognition (Levin, 2013).  The majority of the 
evidence for nicotinic acetylcholine receptor involvement in cognition comes from evidence that 
an agonist such as nicotine and receptor activation is responsible for cognitive improvements.  
1LFRWLQHDQGQ$&K5V¶UROHLQFRJQLWLRQLVLPSRUWDQWIRUXQGHUVWDQGLQJDGGLFWLRQDQGIRU
understanding disease pathology where attentional impairments are seen. 
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 The ascending cholinergic system originating in the basal forebrain and projecting to the 
cortex is very important in mediating sustained attention (Lawrence et al. 2002).  Microdialysis 
studies can measure the amount of acetylcholine released during tasks that require sustained 
attention, and they have found that there is a large and sustained increase in acetylcholine efflux 
in animals actively performing an attentionally demanding task (Dalley et al. 2001).  The 
increases in acetylcholine release were seen specifically in the medial prefrontal cortex and the 
orbitofrontal cortex, which implicates cortical acetylcholine in attentional processes.  Other 
studies have also implicated release of acetylcholine in the frontal and parietal cortices (Sarter, 
Parikh, and Howe 2009).  The amount of acetylcholine release measured on different tasks 
suggests that the levels of ACh release are indicative of the demands on attentional performance.  
Relatedly, D4ȕDJRQLVWVKDYHEHHQVKRZQWRHQKDQFHFXHGHWHFWLRQE\LQFUHDVLQJWKHDPSOLWXGH
of signal-evoked cholinergic transients (Sarter, Parikh, and Howe 2009).  The prefrontal cortex 
has also been implicated in cue-detection, so the ACh efflux in that area during attentional 
demands lends support to this theory.  The ACh efflux in the prefrontal cortex is accompanied by 
prefrontal glutamate release that is mediated by thalamic glutamatergic afferents.  When the 
ĮȕQ$&K5VORFDWHGLQWKHWKDODPXVDUHDFWLYDWHGWKey stimulate glutamate release in the 
prefrontal cortex, which has also been implicated in cue detection and attentional performance 
(Grupe et al. 2013).  Nicotine administration also causes increased activity in the parietal cortex 
and attentional improvements (Lawrence et al. 2002).  Nicotine-induced performance 
enhancements have been seen in a rapid visual information-processing task, which requires 
VXVWDLQHGDWWHQWLRQDQGZRUNLQJPHPRU\DQGDOVROHQGVVXSSRUWWRWKHFKROLQHUJLFV\VWHP¶V
involvement in cue detection (Lawrence et al. 2002). 
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 The top-down executive functions of attention are responsible for weighing rewards 
against each other (i.e. reward discounting) and suppression of preemptive responses, both of 
which are aspects of impulsivity (Sarter and Paolone 2011).  Attentional processes are also 
involved in modulation of working memory.  The cholinergic system has been implicated in 
attention, memory, and impulsivity.  It appears that the cholinergic system controls attentional 
processes, which in turn affects impulsivity.                
0XOWLSOHVWXGLHVKDYHVKRZQYDULRXVDVSHFWVRIDFHW\OFKROLQH¶VLQYROYHPHQWLQPHPRU\
7KHLQWHUHVWKHUHDVZHOODVIRUDFHW\OFKROLQH¶VLQYROYHPHQWLQDWWHQWLRQLVLQWUHDWPHQWSRWHQWLDO
for disorders involving impulsivity.  Attention relates impulsivity and working memory, and so 
what affects impulsivity will also have an effect on working memory, and vice versa.  Infusions 
RIKLJKGRVHVRIĮȕRUĮQ$&K5DQWDJRQLVWVGLUHFWO\LQWRWKHKLSSRFDPSXVFDXVHGZRUNLQJ
memory impairments, suggesting the hippocampal nAChRs are important for memory (Felix and 
Levin 1997).  While most nAChRs are located presynaptically, there is evidence that some are 
located postsynaptically and when activated, depolarize neurons, increase their firing rate, and 
contribute to long-term potentiation (Colombo et al. 2013).  Long-term potentiation is a crucial 
process for learning and memory.   Similar to the effects of nicotine on attention, memory can 
also be improved by nicotine administration and is accompanied by increased activity in the 
frontal cortical regions of the brain (Kumari, Grey, and Ffyche 2003).   
In support of cholinergic involvement in attention and memory, one of the hallmarks of 
$O]KHLPHU¶V'LVHDVHLVDVLJQLILFDQWUHGXFWLRQLQFRUWLFDOQLFRWLQLFFKROLQHUJLFUHFHSWRUELQGLQJ
relative to subjects of the same age (Newhouse et al. 2001).  The memory impairments in 
animals that have received lesions to their cholinergic projections to the hippocampus to model 
$O]KHLPHU¶VGLVHDVHFDQEHUHYHUVHGE\QLFRWLQHDGPLQLVWUDWLRQ<DPD]DNL+DPDXHDQG
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Sumikawa 2002).  The cholinergic lesions disrupt the induction of long-term potentiation (LTP), 
a crucial working memory process.  Nicotine administration can reverse these deficits by 
enhancing the NMDA receptor response on hippocampal neurons expressing nAChRs.  This 
particular study demonstrates the role of nicotine and nAChRs in attention, but also points out 
that in the absence of endogenous acetylcholine release, the actions of nicotine were as a result 
of nAChR activation, not desensitization.   
Decreased cholinergic system activity has also been implicated in attention-
deficit/hyperactivity disorder (ADHD).  In addition to attentional impairments, ADHD patients 
exhibit various aspects of impulsivity.  ADHD patients typically lack behavioral inhibition, 
which is the ability to delay or refrain from responding due to environmental cues (Potter and 
Newhouse 2008).  This effect may be the result of a combination of decreased cue detection and 
heightened impulsivity, however, it has been suggested that the deficits in sustained attention are 
secondary to the deficits in inhibition in the case of ADHD (Potter and Newhouse 2008).  Even 
so, there is very high comorbidity between smokers and ADHD patients.  Adolescents with 
ADHD are both more likely to become smokers and more likely to start smoking at a younger 
age than controls (Riggs et al. 1999).  The severity of impulsivity symptoms are a better 
SUHGLFWRURIOLIHWLPHVPRNLQJEHKDYLRUWKDQWKHLQDWWHQWLYHV\PSWRPVEXWFRQVLGHULQJQLFRWLQH¶V
beneficial effect on attention, it is also possible that ADHD patients smoke to self-medicate and 
address the cognitive dysfunction not treated by most mainstream ADHD therapies (Potter and 
Newhouse 2008, Wilens and Decker 2007).  Similar to patients affected by ADHD, it is thought 
that schizophrenic patients smoke to correct cognitive deficits as well.  The negative symptoms 
and cognitive deficits of schizophrenia are the best predictor of functional outcome for the 
patient, and nicotine administration can help relieve some of those cognitive issues.  
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Interestingly, nicotine administration actually decreases impulsivity and increases behavioral 
inhibition in an animal model of schizophrenia (Scott and Taylor 2014).   
+RZHYHUQLFRWLQH¶VFRJQLWLYHEHQHILWVRQO\FRPHDIWHUWROHUDQFHWRQLFRWLQH¶VDGYHUVH
physiological effects.  Hahn and Stolerman showed that nicotine produced 8 weeks of stable 
enhanced attention after a week of poor performance.  Initial administration of nicotine can 
induce nausea because the area postrema in the brain stem recognizes nicotine as a poison.  The 
adverse side effects produced by nicotine are known generally as dysphoria, but can include, 
WHQVLRQDQ[LHW\QDXVHDDQGQHUYRXVQHVV1LFRWLQH¶VDGYHUVHVLGHHIIHFWVDUHHYLGHQWLQRWKHU
studies, even if they are not explicitly stated.  In a study done by Kirshenbaum et al. (2011), the 
behavioral effects of nicotine were only seen after repeated administration, not initial exposure.  
Initial administration of nicotine proved to be too disruptive and tolerance to the dysphoria was 
needed.  These results have been seen in drug-naïve animals and non-smoking humans 
(Semenova et al. 2007, Foulds et al. 1997).    
Nicotine and Impulsivity 
 As mentioned above, nicotine has been implicated in impulsivity in human and animal 
models. Nicotine has been shown to increase impulsivity in humans with both acute and routine 
systemic administration.  The effects of systemic nicotine depend on where it binds in the brain 
and at what concentration.  We have hypothesized that activation of the D4E2 nAChRs in 
particular are responsible for mediating impulsive behavior in the probability-discounting task.  
Ohmura et al. (2012) showed that administration of an D4E2 antagonist in the absence of 
nicotine suppressed impulsive choice on a 3-choice serial reaction time task, but an D7 nAChR 
antagonist did not.     
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Most studies have shown that nicotine increases impulsive choice in a delay-discounting 
task.  Kolokotroni et al. (2011) used a delayed reward task to look at impulsive choice and a 
symmetrically reinforced go/no-go task to look at behavioral inhibition.  In this study, 
impulsivity was defined as being made up of impulsive choice behaviors and failure of inhibitory 
control, referred to as behavioral disinhibition.  In this study, nicotine increased impulsive 
choice, defined as preference for the smaller, immediate reward, and dose-dependently increased 
behavioral disinhibition.  Administration of a non-competitive, non-selective nicotinic 
acetylcholine receptor antagonist, mecamylamine, blocked both of these results when 
administered with nicotine.  Nicotine administration in patients with ADHD or schizophrenia 
decreased behavioral inhibition, suggesting that abnormalities in this aspect of impulsivity are 
part of these diseases (Kolokotroni et al. 2011).  Another study done by Kirshenbaum et al. 
(2011) corroborates the results in the Kolokotroni et al. (2011) study by finding that repeated, but 
not initial, administration of nicotine increased behavioral disinhibition in rats performing a 
conjunctive variable-interval differential-reinforcement-of-low-rate task and a stop-signal task.  
Mecamylamine also blocked the increased behavioral disinhibition when administered with 
nicotine in this task.  Dallery and Locey (2005) used a delay-discounting task to show that acute 
and chronic nicotine injections both increased impulsive choice in rats with sustained, but 
reversible, effects.  This experimental design is different from most delay-discounting tasks in 
that an indifference delay was determined for each rat and each test session started with the 
indifference delay and increased from there.  An indifference delay is the delay at which the 
animal has no preference for either reward.  They found that acute nicotine injections dose-
dependently increased preference for the small, immediate reward and that chronic nicotine 
administration increased impulsive choice, regardless of dose.  The increased impulsive choice 
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seen with chronic nicotine persisted for 30 test sessions after nicotine administration had 
stopped.   
At odds with these results is a study done by Yonezaki, Fadel, and Burk (in preparation). 
They found that exposure, abstinence, and re-exposure to nicotine increased preference for the 
large, delayed reward in rats, a trend that is generally thought of as decreased impulsivity.  There 
are a few ways to interpret this result.  One is that the nicotine increased preference for the large, 
delayed reward by relieving responses to negative consequences.  The nicotine made the rats less 
sensitive to the consequences of their choice.  Another possible explanation for this result is that 
nicotine administration leads to perservative behavior.  This theory is supported by a study done 
by Mendez et al. (2013) who looked at nicotine administration on ascending and descending 
probability-discount tasks.  On the descending probability-discounting task, the rats that received 
nicotine were more likely to choose the large reward.  The results from the ascending 
probability-discounting task, however, were the opposite.  Nicotine exposure increased 
preference for the smaller, certain reward.  On an ascending probability-discounting task, all the 
rats begin choosing the small reward because it is the better choice, so it is possible that nicotine 
LVDIIHFWLQJWKHUDW¶VDELOLW\WREHIOH[LEOHLQFKDQJLQJWDVNSDUDPHWHUV7KHSerservative behavior 
refers to the fact that the rats keep choosing the same reward because that is the reward they 
started choosing at the beginning of the task.        
Semenova et al. (2007) investigated the effects of low and high doses of nicotine in two 
different strains of rats with different baseline levels of cognition.  In the baseline 5-choice serial 
reaction time task, Wistar rats performed better than Sprague Dawley rats.  In the Wistar rats, the 
only significant effect of nicotine was increased impulsivity at the highest dose of nicotine 
(0.14mg/kg).  The Sprague Dawley rats showed more attentional benefits at the highest dose of 
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nicotine with more correct responses, but no change in response latency was observed.  These 
results suggest that in an organism with below baseline levels of attentional processing, nicotine 
can improve attention, but an organism with baseline attention only exhibits increased 
impulsivity. 
The relationship between nicotine and impulsivity on a probability-discounting task is not 
as strong as the relationship between nicotine and impulsivity on a delay-discounting task.  
Ohmura et al. (2005) looked at nicotine intake in smokers and measured their performance on 4 
discounting tasks (delay and probability discounting of monetary gains and losses).  The only 
significant result was that higher doses of nicotine were associated with a greater tendency to 
discount delayed rewards.  This also suggests that discounting rewards and losses are processed 
differently in the brain.  In a different probability-discounting paradigm, Mitchell et al. (2011) 
conducted a study where there was a small, safe reward and a large, risky reward that was 
sometimes accompanied by a foot shock.  As the test session progressed, the probability of the 
rat receiving the foot shock with the large reward went up.  This study found that nicotine caused 
a significant decrease in the choice of the large, risky reward.  However, this study did not rule 
out the possibility that this behavioral result was the product of any of the adverse effects of 
nicotine.  The nicotine could have induced nausea, decreased appetite, or increased tension in the 
animal, and any of the effects could have contributed to their result.  In the presented study, 
water was used as a reward (Yonezaki et al. in preparation).     
We have hypothesized that nicotine administration will increase preference for the large, 
risky reward on the probability-discounting task.  Based on the presented evidence, we also 
hypothesized that blocking the D4E2 nicotinic acetylcholine receptors with DHEE before 
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nicotine administration will block the behavioral effects of nicotine on the probability-
discounting task.  
Materials and Methods 
Subjects, Experiment 1 
12 male FBNF1 rats were housed in pairs in a temperature- and humidity-controlled 
room with a 14/10 hour light/dark cycle.  Food pellets were available to the subjects in their 
home cage throughout the experiment.  Tap water was available to the subjects for 30 minutes 
after each test session in their home cages.  The subjects were tested once a day, 7 days a week 
for the duration of the experiment.  The experimental procedures were approved by the 
Institutional Animal Care and Use Committee at the College of William & Mary.   
Apparatus 
The rats were trained in one of four test chambers, and were tested in the same chamber 
every day.  Each chamber was in a sound-attenuating box.  One side of the chamber contained 
two ports equipped with photocells to detect nose pokes and a dipper with a cup that could be 
raised to allow water access.  One dipper cup contained 0.01mL of water and the other contained 
0.06 mL of water.  The large reward was located in the right port of two chambers and in the left 
port of the other two chambers.  A panel light was located above each water port and above the 
lever.  A house light was located on the opposite side of the chamber and remained illuminated 
during all behavioral testing sessions.  Behavioral testing programs were controlled by a 
computer using MED-PC IV software. 
Behavioral training prior to drug administration 
Rats were shaped to perform the probability-discounting task prior to nicotine exposure. 
The first stage of behavioral training was water port training, where all lights in the box were 
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illuminated and both rewards were available with a nose poke into the water port.  Criterion for 
moving onto the next stage of training was entering the water port at least 80 times per test 
session.  In the next stage of testing, appropriate port entries were guided by the panel lights 
above the ports.  During this training stage, a trial was initiated with a lever press. 
 In the final task, the trial began with a lever extension.  A press on the lever initiated a 
trial.  There were three blocks of trials within each session, with 24 trials in each block.  The first 
12 trials in each block were forced trials in which only the left or the right panel light was 
illuminated and a nose poke in the port under that light led raising of the dipper 100% of the time 
in the small reward port, or, in the large reward port, the dipper was raised the proportionate 
amount of times for the probability that would be tested in that block.  There were 6 forced trials 
for each port, but the order of the forced trials was random.  After completing the 12 forced 
trials, the block consisted of 12 free choice trials, in which both panel lights were illuminated.  If 
the rat did not nose poke in either port during the 10s in which the panel lights were illuminated, 
that trial was scored as an omission.  After an omission, the panel lights turn off and a 60s 
intertrial interval (ITI) was initiated.  A nose poke in the small reward port resulted in the small 
reward 100% of the time.  In subsequent trial blocks, the probability of the rat receiving the large 
reward after a nose poke in the large reward port declined.  In the first block, the large reward 
was available 100% of the time.  In the second block, the large reward was available 33% of the 
time, and then it was available 17% of the time in the last block of trials.  After either dipper was 
raised, a 60s ITI occurred.  
Nicotine administration, Experiment 1 
 Nicotine bitartrate salt was dissolved in saline, with pH adjusted to 6.8-7.4.  All doses 
were administered using intraperitoneal (IP) injections made at a volume of 1.0mL/kg.  On days 
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1-4, rats received either nicotine (0.4mg/kg) or saline twice per day.  In each squad of four 
animals, there were two nicotine-exposed rats and two saline-exposed rats, with one nicotine- 
and one saline-exposed animal in chambers with the small reward on the left side of the chamber 
in each squad.  Across the three squads, at least one rat from each condition (nicotine or saline) 
was trained in each box.  The first injection took place directly before placing the animals in the 
test chambers, and the second injection took place 3-4 hours after behavioral testing.  On day 5, 
all rats received a challenge dose of nicotine (0.1mg/kg) before testing. On days 6 and 7, all rats 
received saline injections before testing.  On day 8, all rats received a challenge nicotine dose 
(0.1mg/kg) directly before being placed in the testing chamber.  On days 9-11, all rats received 
saline injections before behavioral testing.  On day 12, all rats received their final challenge 
nicotine dose (0.4mg/kg) directly before being placed in the testing chamber. 
Subjects, Experiment 2 
 12 adult male Sprague Dawley rats were housed in pairs in a temperature- and humidity-
controlled room on a 14/10 hour light/dark cycle.  Food was available ad libitum when the rats 
were in their home boxes.  Water was used as the reward during testing and was available to the 
rats for 30 minutes immediately after testing.  The subjects were tested once a day for the 
duration of the experiment.  The experimental procedures were approved by the Institutional 
Animal Care and Use Committee at the College of William & Mary.       
Drug administration, Experiment 2 
 The same behavioral training from experiment 1 was used in this experiment and nicotine 
(0.4 mg/kg) was also prepared in a similar manner to experiment 1.  Dihydro-E-erythroidine 
(DHEE; Sigma), an D4E2 nAChR antagonist, was dissolved in saline and administered in 
volumes of 1.0 mL/kg.  We used a DHEE concentration of 1 mg/kg (Davis and Gould 2006).  
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Rats received injections on Mondays, Wednesdays, and Fridays, with normal behavioral training 
occurring on days when there were no injections.  Each rat received four injections 
(saline/vehicle, nicotine/vehicle, saline/DHEE, nicotine/DHEE) in a randomized order with at 
least two days between each injection.  DHEE was injected 15 minutes prior to testing and the 
nicotine was injected 10 minutes prior to testing.  
Behavioral measures and statistical analyses 
 The probability of selecting the large reward was determined (number of entries into 
large reward port/total number of port entries) for each block of free choice trials.  Behavioral 
measures were analyzed with ANOVAs, with factors being drug, block, and (in Experiment 1) 
day.  A level of D = 0.05 was used for significance.  For experiment 1, we also conducted a two-
tailed t-test.  One-way ANOVAs between blocks for each drug treatment were conducted on the 
data for experiment 2. 
Results 
Experiment 1 
 A drug (saline versus nicotine) X block X day ANOVA was conducted to test whether 
nicotine affected the probability of entering the large reward port.  There were no significant 
effects or interactions involving day, so the data were averaged across the 12 days of the 
experiment and a drug X block ANOVA was conducted.  We found significance in the between 
groups interactions.  In this experiment, drug (saline versus nicotine) is a between subjects factor 
and block is a within subjects factor.  The main effect of block (F(2,20) = 82.95, p < .05) shows 
that there was a significant difference in the probability of entering the large reward port between 
the two groups of rats (saline pre-exposed and nicotine pre-exposed) across blocks.  The 
percentage by group interaction was also significant (F(2,20) = 4.876, p < .05).  A follow-up 
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two-tailed t-test was conducted and showed decreasing p values for each block of the test 
session, approaching significance at block 3 (block 1: p = 1.00, block 2: p = 0.253, block 3: p = 
0.065).      
Experiment 2 
 To assess the effects of nicotine alone, we conducted an ANOVA involving drug 
(saline/vehicle versus nicotine/vehicle) and block as factors. The interaction between 
saline/vehicle and nicotine/vehicle reaches significance (p = .019), which corroborates our result 
from project 1 (see Figure 2).   We then assessed the affects of DHEE alone in a drug 
(saline/vehicle versus saline/DHEE) X block AVOVA (see Figure 3).  There was no significant 
interaction between these two groups, but the one-way ANOVA between blocks for 
saline/DHEE did not reach significance (p = 0.092).  In comparison, the one-way ANOVA 
between blocks for saline/vehicle did reach significance (p = 0.004).  To assess whether blocking 
the D4E2 nicotinic acetylcholine receptors impacted the effects of nicotine, we conducted a drug 
(nicotine/vehicle versus nicotine/DHEE) X block AVOVA.  In these analyses, drug and block 
are both within subjects factors. It does not appear that the behavior seen in the probability-
GLVFRXQWLQJWDVNLVPHGLDWHGE\WKHĮȕQ$&K5V Examination of group means indicated that 
nicotine exposure increased the likelihood of entering the large reward port compared to saline 
administration, as the probability of receiving the large reward decreased. DHEE alone did not 
affect performance, as a drug  (saline/vehicle versus saline/DHEE) X block ANOVA did not 
yield any significant effects. Similarly, DHEE did not impact the effects of nicotine on 
probability discounting, as there were no significant effects involving drug in a drug 
(nicotine/vehicle versus nicotine/DHEE) X block ANOVA (see Figure 4).  One-way ANOVA 
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analyses between blocks for each nicotine/vehicle and nicotine/DHEE drug conditions did not 
reach significance (p = 0.807 and p = 0.866, respectively).   
Discussion 
 The differences in the probability of entering the large reward port seen between the 
nicotine and saline pre-exposed groups in experiment 1 can be interpreted as an increase in risky 
behavior, or an increase in that aspect of impulsivity.  The rats that were pre-exposed to nicotine 
chose the larger reward more than the saline pre-exposed rats as the reward became less 
advantageous.  Our findings from experiment 2 suggest that this behavior is not mediated by the 
D4E2 nicotinic acetylcholine receptors. 
 Looking at the graphical results from experiment 1 (see Figure 1), it is important to note 
that the saline and nicotine pre-exposed rats exhibited similar percentages of entering the large 
reward port in the first block when the large reward was available 100% of the time.  Both 
groups of rats almost always entered the large reward port in block 1, suggesting that both 
groups of rats are capable of discriminating between the large reward and the small reward.  
Also, this result indicates that the nicotine administration did not affect motivation for the 
reward.   
 In Experiment 2, saline/vehicle-exposed rats demonstrated the expected decrease in 
preference for the larger reward as the probability of receiving that reward declined.  Following 
nicotine/vehicle administration, on the other hand, rats did not significantly alter the probability 
of entering the large reward port even when the probability of receiving the reward declined.  In 
block 1, nicotine/vehicle caused a lower percentage of large reward choice, possibly due to 
nicotine-induced dysphoria.  There was no significant difference in the performance of the rats 
between saline/vehicle and saline/DHEE, which tells us that blockade of D4E2 nAChRs does not 
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affect performance on this task.  Blocking the D4E2 nAChRs in the presence of nicotine did not 
alter the effects of nicotine on percentage of choosing the large reward. However, this result 
could be a product of the WLPLQJRI'+ȕ(DGPLQLVWUDWLRQ:HGHFLGHGWRDGPLQLVWHUWKH'+ȕ(
PLQXWHVEHIRUHQLFRWLQHDQGWKHUHKDVEHHQQRFRQVHQVXVRQZKHQWRDGPLQLVWHU'+ȕ('+ȕ(
has been administered 25 minutes before nicotine and 30 minutes before behavioral testing or it 
has been administered in conjunction with nicotine (Davis and Gould 2006, Reuben and Clarke 
2000).          
It is encouraging to see that even one dose of nicotine in experiment 2 was enough to 
create a trend similar to what we saw with pre-exposure to nicotine in experiment 1.  In both 
experiments, as the probability of receiving the large reward declined, the rats who were exposed 
to saline chose the large reward significantly less with each subsequent block.  The rats who 
were exposed to nicotine did not exhibit this exact behavior in either experiment.  Looking at 
results from both experiments, nicotine appears to stabilize choice of the large reward, even as 
the probability of receiving the reward declines.  The behavioral differences seen in block 1 of 
experiment 1 and experiment 2 can be explained by the dysphoria caused by initial nicotine 
administration (Semenova et al. 2007, Foulds et al. 1997).  The animals in experiment 1 had 
previous exposure to nicotine, so when they were initially put into the test boxes, they may not 
have been as susceptible to the dysphoria nicotine can cause upon initial administration.  The 
animals in experiment 2 required more time before they were able to perform at peak levels 
during each behavioral test session because they had no tolerance to nicotine.   
It is still unclear whether the effect seen in both experiment 1 and experiment 2 is due to 
a nicotine-induced increase in risky behavior or due to a nicotine-induced increase in 
perservative behavior.  Mendez et al. (2013) showed that nicotine increased perservative 
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behavior in descending and ascending probability tasks.  Based on the Ohmura et al. (2005) 
results, the relationship between nicotine and probability discounting is not nearly as strong as 
the relationship between nicotine and delay discounting.  In experiment 2, the lack of 
UHODWLRQVKLSEHWZHHQWKHĮȕQLFRWLQLFDFHW\OFKROLQHUHFHSWRUVDQGEHKDYLRURQWKHSUREDELOLW\-
discounting task suggests that risky behavior might be mediated by another receptor subtype.  It 
LVSRVVLEOHWKDWWKLVEHKDYLRUFRXOGEHPHGLDWHGE\WKHĮQLFRWLQLFDFHW\OFKROLQHUHFHSWRUV
which are the second most widespread nicotinic acetylcholine receptor subtype in the brain 
1DVKPLDQG/HVWHU7KHĮQ$&K5VKDYHDPXFKORZHUDIILQLW\ for nicotine than the 
ĮȕUHFHSWRUVZKLFKFRXOGH[SODLQZK\WKHUHODWLRQVKLSEHWZHHQQLFRWLQHDQGULVN\EHKDYLRURQ
the probability-discounting task is not as robust as the relationship between nicotine and delay 
discounting.  Very little research looking specifically at perservative behavior or lack of 
behavioral adaptability following nicotine exposure has been reported, so that would be an 
interesting future direction. 
Considering the high incidence of smoking with other impulsive and compulsive 
conditions such as drug addiction, it is important to investigate the relationship between nicotine 
and impulsivity (Weafer and de Wit 2013).  It might be that those who start smoking have a 
higher baseline of risky behavior to begin with, but our results from experiment 1 show that 
nicotine administration increases the probability of choosing the riskier reward in rats that have 
been pre-exposed to nicotine.  Impulsivity is a component of the proposed endophenotype for 
substance use disorders, so greater impulsivity could be a risk factor for substance use disorders, 
as well as a possible consequence (Robbins et al. 2012).  If the heightened impulsivity is the 
result of differential expression or activity of nicotinic acetylcholine receptors, then related genes 
could be investigated to better understand the genetic underpinnings of substance use disorders.  
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It is also important to investigate the relationship of impulsivity, attention, and nicotinic 
DFHW\OFKROLQHUHFHSWRUVLQGLVHDVHVVXFKDV$O]KHLPHU¶VDQGVFKLzophrenia, however the 
experiments presented here were conducted on wild-type rats, and not animal models of these 
diseases.       
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Figure Legends 
Figure 1 
The graph is a visual representation of the significant between-groups interaction.  The 
two groups exhibit the same behavior, namely a decrease in how often they choose the large, 
riskier reward, but the saline pre-exposed group exhibited that behavior to a larger degree.  The 
significance is in the difference in the behavioral changes between the groups.  It is also 
important to note that both groups behaved exactly the same during the first block of 100% 
probability.  The nicotine injections did not affect motor activity or desire for water.  All changes 
were as a result of the changes in probability, not adverse effects to nicotine. 
Figure 2 
This figure shows the effects of nicotine administration compared to saline.  The 
interaction between the two groups is significant.  The behavior in block 1 can be explained by 
the dysphoria caused by initial nicotine exposure.  The one-way ANOVA for saline/vehicle 
demonstrates that the behavior for that drug condition was significantly different from block to 
block during the test session.  The one-way ANOVA for nicotine/vehicle was not significant, and 
it is clear that the behavior was not significantly different from block to block during the test 
session. 
Figure 3 
 This figure shows that DHEE administration alone did not significantly alter the behavior 
of the rats.  The interaction between the saline/vehicle condition and the saline/DHEE condition 
was not significant.  While the one-way ANOVA for saline/vehicle was significant, the one-way 
ANOVA for saline/DHEE was not, as indicated by the two lines not being a perfect overlap.  The 
difference in block 3 was not statistically significant. 
26 
Figure 4 
 As seen in this graph, administering DHEE and nicotine did not impact the behavioral 
effects of nicotine.  The two drug conditions exhibit almost exactly the same behavior.  There is 
no statistical significance in the interaction between the nicotine/vehicle and nicotine/DHEE 
groups, and neither one-way ANOVA showed significance.  DHEE administration did not inhibit 
the effects of nicotine, so the behavior seen is not medicated by the D4E2 nicotinic acetylcholine 
receptors. 
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